This page shows the latest Novo Nordidsk news and features for those working in and with pharma, biotech and healthcare.
Novo is claiming that Ozempic’s launch has “stabilised” its GLP-1 market share at around 26%. ... Novo’s CEO Lars Fruergaard Jørgensen said that 2018 was a “year of change” for the company, but also one of “significant progress” as its
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
No results were found
Fox&cat is a new kind of fully-integrated communications agency – one that delivers genuinely inspirational campaigns and programmes with equal...